Alphabet
Latest statistics and disclosures from Alphabet's latest quarterly 13F-HR filing:
- Top 5 stock holdings are CME, PL, ASTS, RVMD, ARM, and represent 83.98% of Alphabet's stock portfolio.
- Added to shares of these 4 stocks: CME (+$1.0B), PL (+$92M), Paypay Corp (+$67M), Ethos Technologies (+$42M).
- Started 3 new stock positions in Ethos Technologies, Paypay Corp, CME.
- Reduced shares in these 9 stocks: DXCM (-$69M), RVMD (-$5.1M), WGS, , GLUE, QNCX, FULC, RGEN, RLAY.
- Sold out of its positions in QNCX, DXCM, EXACT Sciences Corporation, FULC, RGEN, WGS.
- Alphabet was a net buyer of stock by $1.1B.
- Alphabet has $4.0B in assets under management (AUM), dropping by 55.65%.
- Central Index Key (CIK): 0001652044
Tip: Access up to 7 years of quarterly data
Positions held by Alphabet consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Alphabet
Alphabet holds 26 positions in its portfolio as reported in the March 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Cme (CME) | 25.6 | $1.0B | NEW | 3.5M | 295.35 |
|
| Planet Labs Pbc Com Cl A (PL) | 24.5 | $985M | +10% | 35M | 27.95 |
|
| Ast Spacemobile Com Cl A (ASTS) | 18.5 | $741M | 8.9M | 82.87 |
|
|
| Revolution Medicines (RVMD) | 8.0 | $320M | 3.3M | 97.25 |
|
|
| Arm Holdings Sponsored Ads (ARM) | 7.4 | $297M | 2.0M | 151.28 |
|
|
| Freshworks Class A Com (FRSH) | 3.2 | $130M | 16M | 8.03 |
|
|
| Uipath Cl A (PATH) | 1.9 | $78M | 7.0M | 11.10 |
|
|
| Tempus Ai Cl A (TEM) | 1.7 | $70M | 1.6M | 45.22 |
|
|
| Paypay Corp Sponsored Ads | 1.7 | $67M | NEW | 3.1M | 21.34 |
|
| Gitlab Class A Com (GTLB) | 1.5 | $59M | 2.7M | 21.64 |
|
|
| Prime Medicine (PRME) | 1.4 | $58M | 17M | 3.48 |
|
|
| Ethos Technologies Cl A | 1.0 | $42M | NEW | 3.8M | 11.17 |
|
| Maze Therapeatics (MAZE) | 1.0 | $41M | 1.4M | 29.85 |
|
|
| Bridgebio Oncology Therapeut Com New (BBOT) | 0.6 | $25M | 2.8M | 8.95 |
|
|
| Relay Therapeutics (RLAY) | 0.4 | $16M | 1.6M | 9.95 |
|
|
| Monte Rosa Therapeutics (GLUE) | 0.3 | $11M | -8% | 684k | 16.45 |
|
| Vera Therapeutics Cl A (VERA) | 0.2 | $9.7M | 241k | 40.23 |
|
|
| Sana Biotechnology (SANA) | 0.2 | $8.1M | 2.8M | 2.88 |
|
|
| Beam Therapeutics (BEAM) | 0.2 | $7.7M | 322k | 23.83 |
|
|
| Lyell Immunopharma Com New (LYEL) | 0.1 | $5.9M | 293k | 20.06 |
|
|
| Oscar Health Cl A (OSCR) | 0.1 | $5.5M | 482k | 11.47 |
|
|
| Figma Class A Com Stk (FIG) | 0.1 | $4.6M | 216k | 21.14 |
|
|
| Spero Therapeutics (SPRO) | 0.1 | $2.1M | 890k | 2.34 |
|
|
| Hyperfine Com Cl A (HYPR) | 0.0 | $971k | 899k | 1.08 |
|
|
| Autolus Therapeutics Spon Ads (AUTL) | 0.0 | $964k | 698k | 1.38 |
|
|
| Tenaya Therapeutics (TNYA) | 0.0 | $632k | 916k | 0.69 |
|
Past Filings by Alphabet
SEC 13F filings are viewable for Alphabet going back to 2022
- Alphabet 2026 Q1 filed May 8, 2026
- Alphabet 2025 Q4 filed Feb. 13, 2026
- Alphabet 2025 Q3 filed Nov. 7, 2025
- Alphabet 2025 Q2 filed Aug. 1, 2025
- Alphabet 2025 Q1 filed May 2, 2025
- Alphabet 2024 Q4 filed Feb. 7, 2025
- Alphabet 2024 Q3 filed Nov. 8, 2024
- Alphabet 2024 Q2 filed Aug. 2, 2024
- Alphabet 2024 Q1 filed May 3, 2024
- Alphabet 2023 Q4 filed Feb. 9, 2024
- Alphabet 2023 Q3 filed Nov. 13, 2023
- Alphabet 2023 Q2 filed Aug. 4, 2023
- Alphabet 2023 Q1 filed May 11, 2023
- Alphabet 2022 Q4 filed Feb. 14, 2023
- Alphabet 2022 Q3 filed Nov. 15, 2022
- Alphabet 2013 Q4 filed Nov. 15, 2022